These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1296037)

  • 21. Survey and clinical application of serum iron, total iron binding capacity, transferrin saturation, and serum ferritin in captive black and white ruffed lemurs (Varecia variegata variegata).
    Crawford GC; Andrews GA; Chavey PS; Dunker FH; Garner MM; Sargent EL
    J Zoo Wildl Med; 2005 Dec; 36(4):653-60. PubMed ID: 17312723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlations between abnormal iron metabolism and non-motor symptoms in Parkinson's disease.
    Xu W; Zhi Y; Yuan Y; Zhang B; Shen Y; Zhang H; Zhang K; Xu Y
    J Neural Transm (Vienna); 2018 Jul; 125(7):1027-1032. PubMed ID: 29748849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Metals and oxidative stress in Parkinson's disease from industrial areas with exposition to environmental toxins or metal pollution].
    Squitti R; Gorgone G; Binetti G; Ghidoni R; Pasqualetti P; Draicchio F; Albini E; Benedetti L; Lucchini R; Rossini PM
    G Ital Med Lav Ergon; 2007; 29(3 Suppl):294-6. PubMed ID: 18409692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between sex, systemic iron variation and probability of Parkinson's disease.
    Mariani S; Ventriglia M; Simonelli I; Bucossi S; Siotto M; Donno S; Vernieri F; Squitti R
    Int J Neurosci; 2016; 126(4):354-60. PubMed ID: 26000822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum iron and ferritin level in idiopathic Parkinson.
    Farhoudi M; Taheraghdam A; Farid GA; Talebi M; Pashapou A; Majidi J; Goldust M
    Pak J Biol Sci; 2012 Nov; 15(22):1094-7. PubMed ID: 24261127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The correlation of transferrin saturation and ferritin in non-splenectomized thalassemic children.
    Wangruangsathit S; Hathirat P; Chuansumrit A; Pakakasama S; Hongeng S
    J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S74-6. PubMed ID: 10730522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of repeated blood donations on the iron status of Iranian blood donors attending the Iranian blood transfusion organization.
    Djalali M; Neyestani TR; Bateni J; Siassi F
    Int J Vitam Nutr Res; 2006 May; 76(3):132-7. PubMed ID: 17048192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Serum iron parameters in chronic hepatitis C patients and comparison of the results before and during antiviral treatment].
    Bolewska B; Wojtacha A; Juszczyk J; Przedwojewski M
    Pol Merkur Lekarski; 2005 May; 18(107):552-5. PubMed ID: 16161954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low plasma uric acid level in Parkinson's disease.
    Annanmaki T; Muuronen A; Murros K
    Mov Disord; 2007 Jun; 22(8):1133-7. PubMed ID: 17443703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma transferrin level correlates with the tremor-dominant phenotype of Parkinson's disease.
    Si QQ; Yuan YS; Zhi Y; Tong Q; Zhang L; Zhang K
    Neurosci Lett; 2018 Sep; 684():42-46. PubMed ID: 29981876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Haemoglobin, serum iron, transferrin, ferritin concentrations and total iron-binding capacity in erythrocyte glucose-6-phosphate dehydrogenase deficiency.
    Wong CT; Saha N
    Trop Geogr Med; 1987 Oct; 39(4):350-3. PubMed ID: 3451411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diurnal variation of serum iron, iron-binding capacity, transferrin saturation, and ferritin levels.
    Dale JC; Burritt MF; Zinsmeister AR
    Am J Clin Pathol; 2002 May; 117(5):802-8. PubMed ID: 12090432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Smoking and haptoglobin phenotype modulate serum ferritin and haptoglobin levels in Parkinson disease.
    Costa-Mallen P; Zabetian CP; Hu SC; Agarwal P; Yearout D; Checkoway H
    J Neural Transm (Vienna); 2016 Nov; 123(11):1319-1330. PubMed ID: 27349967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum ferritin in beta-thalassemia trait.
    Loria A; Konijn AM; Hershko C
    Isr J Med Sci; 1978 Nov; 14(11):1127-31. PubMed ID: 750537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complex I, iron, and ferritin in Parkinson's disease substantia nigra.
    Mann VM; Cooper JM; Daniel SE; Srai K; Jenner P; Marsden CD; Schapira AH
    Ann Neurol; 1994 Dec; 36(6):876-81. PubMed ID: 7998774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brain iron concentrations in regions of interest and relation with serum iron levels in Parkinson disease.
    Costa-Mallen P; Gatenby C; Friend S; Maravilla KR; Hu SC; Cain KC; Agarwal P; Anzai Y
    J Neurol Sci; 2017 Jul; 378():38-44. PubMed ID: 28566175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Changes in iron metabolism in Osler-Rendu disease].
    Livandovskiĭ IuA
    Ter Arkh; 1989; 61(2):109-10. PubMed ID: 2727910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Iron saturation of serum ferritin in patients with adult onset Still's disease.
    ten Kate J; Drenth JP; Kahn MF; van Deursen C
    J Rheumatol; 2001 Oct; 28(10):2213-5. PubMed ID: 11669158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The diagnostic role of serum transferrin receptor in patients with various anemia.
    Ho CH
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Feb; 65(2):55-60. PubMed ID: 12014358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum iron parameters in patients with alcoholic and chronic cirrhosis and hepatitis.
    Jurczyk K; Wawrzynowicz-Syczewska M; Boroń-Kaczmarska A; Sych Z
    Med Sci Monit; 2001; 7(5):962-5. PubMed ID: 11535942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.